Circulation. 2024 Apr 2;149(14):e1028-e1050. doi: 10.1161/CIR.0000000000001201. Epub 2024 Feb 28.
A major focus of academia, industry, and global governmental agencies is to develop and apply artificial intelligence and other advanced analytical tools to transform health care delivery. The American Heart Association supports the creation of tools and services that would further the science and practice of precision medicine by enabling more precise approaches to cardiovascular and stroke research, prevention, and care of individuals and populations. Nevertheless, several challenges exist, and few artificial intelligence tools have been shown to improve cardiovascular and stroke care sufficiently to be widely adopted. This scientific statement outlines the current state of the art on the use of artificial intelligence algorithms and data science in the diagnosis, classification, and treatment of cardiovascular disease. It also sets out to advance this mission, focusing on how digital tools and, in particular, artificial intelligence may provide clinical and mechanistic insights, address bias in clinical studies, and facilitate education and implementation science to improve cardiovascular and stroke outcomes. Last, a key objective of this scientific statement is to further the field by identifying best practices, gaps, and challenges for interested stakeholders.
学术界、工业界和全球政府机构的一个主要关注点是开发和应用人工智能和其他先进的分析工具，以改变医疗保健的提供方式。美国心脏协会支持创建工具和服务，通过为心血管和中风研究、预防以及个人和人群的护理提供更精确的方法，来进一步推进精准医学的科学和实践。然而，目前存在一些挑战，而且很少有人工智能工具被证明可以充分改善心血管和中风护理，从而被广泛采用。本科学声明概述了人工智能算法和数据科学在心血管疾病的诊断、分类和治疗中的使用现状。它还旨在推进这一任务，重点关注数字工具，特别是人工智能如何提供临床和机制见解、解决临床研究中的偏见以及促进教育和实施科学以改善心血管和中风结局。最后，本科学声明的一个主要目标是通过确定利益相关者感兴趣的最佳实践、差距和挑战来进一步推动该领域的发展。
